GlassScriptPhysician profile
Nancy C Curosh
NPI 1942298187
$59,392.17
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $21K · 2021: $6,018.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $26,256.67 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $22,561.26 | 2019-2021 | |
| Lilly USA, LLC | $9,395.49 | 2019-2021 | |
| Novo Nordisk INC | $300.66 | 2019-2020 | |
| Dexcom, INC. | $158.81 | 2019-2020 | |
| Abbott Laboratories | $131.99 | 2019-2020 | |
| Genzyme Corporation | $72.00 | 2020 | |
| Tandem Diabetes Care, INC. | $65.34 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $58.57 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $54.69 | 2019 | |
| Janssen Pharmaceuticals, INC | $54.47 | 2019-2020 | |
| Ibsa Pharma INC. | $45.07 | 2019 | |
| Medtronic Minimed, INC. | $43.39 | 2019 | |
| Abbvie INC. | $42.24 | 2019-2020 | |
| Corcept Therapeutics | $38.76 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $37.06 | 2019 | |
| Lifescan, INC. | $28.32 | 2019 | |
| Shire North American Group INC | $23.75 | 2019 | |
| Insulet Corporation | $12.63 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.00 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Curosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.